This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert A. Mevorach, MD; Guy A. Bogaert, MD; Barry A. Kogan, MD
Department of Urology University of California U-575, Box 0738 San Francisco, CA 94143-0738

Arch Pediatr Adolesc Med. 1995;149(12):1400-1401.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We agree with Drs Robson and Leung that data regarding the pathogenesis of nocturnal enuresis are inconclusive and that the mechanism by which desmopressin acetate (DDAVP) is effective for treatment of the condition is unclear. We find the data reported by Evans and Meadow¹ to be interesting; however, their article does not convince us that children who concentrate their urine will benefit from desmopressin. Of the responders (defined as patients with an improvement of two or more dry nights per week—not an impressive difference!), the mean pretreatment urine osmolality was 506 mmol/kg, with a single patient having a value of 1053 mmol/kg. Furthermore, we do not know how well that one patient responded—perhaps only two dry nights per week, a difference that could be explained by many things other than the medication. We find the results reported by Dimson² to be interesting also. Several patients who concentrated their . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?